The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation

The neurodegenerative disorders such as Parkinson’s disease (PD) or Alzheimer’s disease (AD) are the most common forms of dementia and no pharmacological treatments are to date available for these diseases. Indeed, the only used drugs are symptomatic and no useful to block the progression of the dis...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marialessandra Contino, Nicola A. Colabufo, Elena Capparelli, Ashley I. Bush
Format:	Online
Idioma:	anglès
Publicat:	Frontiers Media SA 2021
Matèries:	RC321-571 Q1-390 Cannabinod system CB2 receptor CB2R inverse AD PD neurodegeneration CB2R agonist Inflammation thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
Accés en línia:	24027
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!